高级检索
当前位置: 首页 > 详情页

Modification of association between prior lung disease and lung cancer by inhaled arsenic: A prospective occupational-based cohort study in Yunnan, China.

文献详情

资源类型:
Pubmed体系:
机构: [1]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, PR China. [2]Department of Cancer Epidemiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 10021, PR China. [3]Divisions of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland, USA. [4]Third People's Hospital of Honghe Autonomous District, Yunnan, PR China. [5]Kunming Medical University, Yunnan, PR China. [6]Lung cancer Center, West China Hospital, Sichuan University, Chengdu, PR China.
出处:
ISSN:

摘要:
Arsenic and prior lung diseases have been shown to increase lung cancer risk; however, little is known about their joint effects. The aim of our study was to analyze the joint effects of inhaled arsenic and prior lung diseases on lung cancer risk within a occupational cohort. The interactions of prior lung diseases and inhaled arsenic were analyzed based on multiplicative and additive scales in the Cox proportional hazards model. Compared with low arsenic exposure and no history of asthma, the hazard ratios (HRs) of high arsenic exposure with asthma, high arsenic exposure without asthma and low arsenic exposure with asthma were 2.61 (95% CI: 1.71-4.00), 2.60 (95% CI: 1.93-3.51) and 2.49 (95% CI: 1.53-4.06), respectively. Based on the multiplicative scale in the Cox proportional hazards model, the HR of the interaction of asthma and arsenic on lung cancer risk was 0.45 (95% CI: 0.25-0.80). Based on the additive scale, the relative excess risk due to interaction between asthma and arsenic was -1.41 (95% CI: -2.81 to -0.02). Our study provides strong evidence that arsenic exposure is associated with lung cancer risk. A significant negative interaction between asthma and arsenic on lung cancer risk is observed.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 3 区 医学
小类 | 2 区 环境科学 2 区 公共卫生、环境卫生与职业卫生 2 区 毒理学
最新[2023]版:
大类 | 3 区 医学
小类 | 2 区 毒理学 3 区 环境科学 3 区 公共卫生、环境卫生与职业卫生
第一作者:
第一作者机构: [1]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, PR China.
通讯作者:
通讯机构: [1]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, PR China. [2]Department of Cancer Epidemiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 10021, PR China. [6]Lung cancer Center, West China Hospital, Sichuan University, Chengdu, PR China. [*1]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, 154 Anshan Street, Tianjin 300052, PR China [*2]Sichuan Lung Cancer Institute/Center, West China Hospital, Sichuan University, 37 Guo Xue Lane, Wuhou District, Chengdu, Sichuan 610041, PR China [*3]Department of Cancer Epidemiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 South, Panjiayuan Lane, Beijing 10021, PR China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43373 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号